BioSpace News Archive

Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at the 23rd Annual CIBC Western Institutional Investor Conference on Thursday, January 30, 2020

Acutus Medical’s next mission is confirmed: AF Symposium, January 23-25, in Washington, D.C. Mission: Possible will highlight Acutus’ continued innovation and advancement of the electrophysiology space by showcasing the AcQMap System.

Quantum Health, the healthcare industry’s first and leading consumer navigation company, today announced the promotion of Steven Knight to chief operating officer (COO).

L2P Research, LLC and Transcell Oncologics, LLC have entered into a partnership with the purpose of marketing and the distribution of Transcell Oncologics, LLC Trans HSC (CD34+), Trans-HSC (PBMC) product line and L2P Research’s humanized mouse models.

Centene Corporation (NYSE: CNC) (“Centene”) announced today that it has completed its acquisition of WellCare Health Plans, Inc. (“WellCare”).

Anemocyte, an innovative Italian company working in the field of cell and gene therapies, with special focus on plasmid production and non-viral gene modification approaches, attends Phacilitate Leaders World (Miami, 21-24 January 2020), a leading event for companies, professionals and investors working in the Advanced Therapy sector.

Maturing sperm cells turn on most of their genes, not to follow their genetic instructions like normal, but instead to repair DNA before passing it to the next generation, a new study finds.

Gateway Health, a managed care organization focused on the total health of its members, today announced that Rhonda Curry has joined the company as its Chief Human Resources Officer.

Partnership Aims to Replicate Successful Milestone Achievement from Revolutionary Joint Drug Discovery Program in Colorectal Cancer

Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced multiple presentations at the upcoming Association for Research in Otolaryngology (ARO) 43rd Annual MidWinter Meeting, to be held January 25-29, in San Jose, California.